| scholarly article | Q13442814 |
| P50 | author | Yueh-Hsin Wang | Q59698161 |
| P2093 | author name string | Meng-Chih Lee | |
| Yu-Ching Li | |||
| Yu-Tse Tsan | |||
| Kuang-Hua Huang | |||
| Yi-Sheng Liou | |||
| Hsin-En Ho | |||
| Wei-Min Chu | |||
| P2860 | cites work | Trends in the prescription of antidiabetic medications from 2009 to 2012 in a general practice of Southern Italy: a population-based study | Q41428692 |
| Gender differences in trends in diabetes prevalence from 1993 to 2008 in Taiwan | Q42849509 | ||
| Statins and the risk of hepatocellular carcinoma in patients with hepatitis C virus infection | Q42990281 | ||
| DPP4 inhibitor-induced polyarthritis: a report of three cases | Q44676392 | ||
| National trends in anti-diabetic treatment in Taiwan, 2000-2009. | Q44754315 | ||
| Risk of bladder cancer in diabetic patients treated with rosiglitazone or pioglitazone: a nested case–control study | Q44980532 | ||
| Trends in drug prescriptions to diabetic patients from 2000 to 2008 in Italy's Lombardy Region: a large population-based study. | Q45253574 | ||
| Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection | Q45360202 | ||
| Trends in the prescription of anti-diabetic medications in the United Kingdom: a population-based analysis. | Q45924271 | ||
| Standards of medical care in diabetes--2008. | Q46828447 | ||
| Thiazolidinediones and cardiovascular outcomes in older patients with diabetes | Q46855431 | ||
| Trends in the use of oral antidiabetic drugs by outpatients in Taiwan: 1997-2003. | Q46942534 | ||
| Circulating dipeptidyl peptidase IV activity correlates with cardiac dysfunction in human and experimental heart failure. | Q47914982 | ||
| Using clinical guidelines designed for older adults with diabetes mellitus and complex health status | Q83202060 | ||
| Glucose-lowering treatment of type 2 diabetes. Part II--Glucose-lowering drugs after metformin: a choice based largely on adverse effects | Q85277408 | ||
| Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes | Q22250883 | ||
| Metformin-associated lactic acidosis: Current perspectives on causes and risk | Q26771648 | ||
| Individualising therapy for older adults with diabetes mellitus | Q28222223 | ||
| Effects of intensive glucose lowering in type 2 diabetes | Q29547736 | ||
| Standards of medical care in diabetes--2013 | Q29620309 | ||
| Prevalence and antihyperglycemic prescribing trends for patients with type 2 diabetes in Italy: a 4-year retrospective study from national primary care data | Q31154369 | ||
| ABC control of diabetes: survey data from National Diabetes Health Promotion Centers in Taiwan | Q33423390 | ||
| Standards of medical care in diabetes--2010. | Q33554238 | ||
| Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis. | Q33718914 | ||
| Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials | Q33785313 | ||
| Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis | Q34031108 | ||
| Changes in oral antidiabetic prescriptions and improved glycemic control during the years 2002-2011 in Japan (JDDM32). | Q34299670 | ||
| Fixed-dose combinations improve medication compliance: a meta-analysis. | Q34659858 | ||
| The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study | Q36001145 | ||
| Improving glucose management: ten steps to get more patients with type 2 diabetes to glycaemic goal. | Q36291041 | ||
| Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes | Q36549321 | ||
| Prescribing pattern of glucose lowering drugs in the United Kingdom in the last decade: a focus on the effects of safety warnings about rosiglitazone | Q36620262 | ||
| Trends in the prescription of antidiabetic medications in France: evidence from primary care physicians | Q36953968 | ||
| Temporal trends in anti-diabetes drug use in TRICARE following safety warnings in 2007 about rosiglitazone | Q37572625 | ||
| Prescription Patterns of Antidiabetic Treatment in the Elderly. Results from Southern Italy | Q37741529 | ||
| A systematic review of adherence, treatment satisfaction and costs, in fixed-dose combination regimens in type 2 diabetes | Q37861744 | ||
| The clinical course of patients with type 2 diabetes presenting to the hospital with sulfonylurea-induced hypoglycemia | Q38228025 | ||
| Pharmacologic treatment of type 2 diabetes: oral medications | Q38350347 | ||
| Recent trends in the use of antidiabetic medications from 2008 to 2013: A nation-wide population-based study from Taiwan | Q38408649 | ||
| Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy | Q38502148 | ||
| Trends in the prescription and cost of diabetic medications and monitoring equipment in England 1991-2004. | Q40266923 | ||
| Recent antihyperglycemic prescribing trends for US privately insured patients with type 2 diabetes | Q40586493 | ||
| Effects of safety warnings and risk management plan for Thiazolidinediones in Taiwan. | Q40649706 | ||
| Sulfonylurea monotherapy and emergency room utilization among elderly patients with type 2 diabetes | Q40783705 | ||
| Sulfonylurea use and risk of hip fractures among elderly men and women with type 2 diabetes | Q41137585 | ||
| P433 | issue | 43 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | type 2 diabetes | Q3025883 |
| P304 | page(s) | e8257 | |
| P577 | publication date | 2017-10-01 | |
| P1433 | published in | Medicine | Q15716652 |
| P1476 | title | The prescribing trend of oral antidiabetic agents for type 2 diabetes in Taiwan: An 8-year population-based study | |
| P478 | volume | 96 |
| Q90835644 | Clinical outcomes of basal insulin and oral antidiabetic agents as an add-on to dual therapy in patients with type 2 diabetes mellitus |
| Q64902975 | Effectiveness and Tolerability of Vildagliptin and the Single Pill Combination of Vildagliptin and Metformin in "Real-World" Management of Type 2 Diabetes Mellitus: The G-FORCE Study. |
| Q64076269 | Efficacy and short-term side effects of sitagliptin, vildagliptin and saxagliptin in Chinese diabetes: a randomized clinical trial |
| Q92238002 | Head-to-Head Comparison of the Hypoglycemic Efficacy and Safety Between Dipeptidyl Peptidase-4 Inhibitors and α-Glucosidase Inhibitors in Patients With Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials |
| Q64886564 | Use of Spontaneous Reporting Systems to Detect Host-Medication Interactions: Sex Differences in Oral Anti-Diabetic Drug-Associated Myocardial Infarction. |
Search more.